Who gets paid next.
India's private-to-public queue, tracked position-by-position: every listing candidate in the Gravitywell firm books, its status, its holders, and what each print re-marks. The DPI calendar for private capital.
~₹5,700 Cr (₹2,700 Cr fresh + OFS) at a reported ~₹60,000 Cr (~$6.8bn): below the $7.5bn private peak; Axis, Kotak, JPMorgan, Citi mandated. The bellwether print for every fintech mark — reports conflict on the discount: ~₹60,000 Cr talk vs '~$2.5bn below the private mark' expectations
The ₹11,000-12,000 Cr issue slips to a reported Feb-May 2027 window: domestic MFs/insurers would bid only ~$4.5bn vs the $7bn mark, so Zepto bridged with a >₹1,000 Cr pre-IPO placement (Nexus, GC in) instead of pricing down. ED/FEMA disclosure unresolved
HR SaaS; 3one4 already exited at 58x into the KKR round: listed comp for SaaS books
Triple cross-hold: the most contested realisation event in the cohort
Construction materials (Hella Infra Market); approved via the confidential route on 23 Jan 2026, silent since — Nexus's next big OFS candidate if it moves
₹6,650 Cr all-fresh issue, band not yet announced: holders locked to post-listing sales; >$1.4bn already realised in 2019
Z47 running ~$200M part-stake sale at ~$5bn; $750M-1bn issue reported at $6-9bn
Fireside sells ₹150 Cr in OFS: the D2C shelf’s benchmark print
₹1,500-2,000 Cr; A91 diluting below 20% to avoid promoter classification. The July filing window passed without papers: stalled until proven otherwise
Bessemer holds >26%: the fintech-infra benchmark print
~$15bn valuation; Tiger and Microsoft exit fully: the highest-stakes pending fintech print
The planned late-2026 SEBI draft filing is no longer active (market volatility, West Asia conflict, congested calendar). SVF2 re-entered ~$700M in 2021; the e-commerce benchmark listing has no date
Middle-India lending's first big public print
Valuation compressed from peak; July's $160M private round funds the runway and defers the public test of B2B commerce marks
₹950 Cr fresh + OFS up to 17.86 Cr shares (~₹4,000 Cr total reported); FY26 revenue ₹1,801.8 Cr +41.6%, loss narrowed to ₹251.9 Cr. Temasek's Mar-2026 ₹440 Cr entry at a flat $1.45bn is the reference mark
Pipeline assembled from DRHP filings, SEBI approvals and tier-1 press reports, cross-referenced against the tracked position books: holders shown are tracked franchises only, not full cap tables. Statuses are point-in-time as of Aug 2026 and never silently restated. Context: 24+ startups had filed DRHPs by mid-2026; the window reopened in July (₹52,300 Cr raised, Manipal +11% on debut) but it prices hard — Shadowfax listed at −9% and Zepto postponed rather than test it — so pricing risk sits in every row above.